In this issue:
Benzodiazepines and AD
Levodopa still the best for PD
PD and smoking revisited
LY2951742 for migraine prevention
Natalizumab in multiple sclerosis
Anticoagulation resumption after TBI
Cost of TBI in NZ
White matter tissue damage after repeated concussion
Benefits of centralising acute stroke services
Treatment outcome after failure of a first antiepileptic drug
Please login below to download this issue (PDF)